Dear Editor,

we hereby would like to discuss the report “Hurley Staging Training for Hidradenitis Suppurativa Patients” [1]. It is agreed that the Hurley stage learning module (HSLM) is useful for improving patient education and self-reporting. The inclusion of Fitzpatrick skin tone and varying hidradenitis suppurativa (HS) severity in the test images allows for a more comprehensive assessment of HS. This increases the clinical applicability of the HSLM and makes it more relevant to a wider range of patients, particularly in populations with diverse skin types who may present with varying HS symptoms. The tool can allow for more accurate monitoring of disease progression and is applicable in telemedicine communication. Moreover, it can show that there is a significantly increased confidence of participants. This will be useful in a tailored treatment plan.

However, Dagenet et al. [1] did not include a control group and there is a possibility of a confounding factors effect such as prior knowledge or the passage of time. Therefore, further study is still necessary to confirm that HSLM was the direct cause of the observed improvements. Future randomized controlled trials to evaluate the effectiveness of the module compared to a control group are recommended. The study should also examine diverse populations, including different levels of severity of the problem and varying skin tones. The module can be greatly enhanced by the effectiveness, engagement, and practical application of incorporating interactive feedback, personalized difficulty adjustment, and clinical case scenarios to increase the accuracy of hidradenitis suppurativa scoring.

The authors declare no conflict of interest.

There is no funding. AI declaration: the authors used a language editing computational tool in the preparation of the article.

A.K. 50% ideas, writing, analyzing, approval. V.W. 50% ideas, supervision, approval.

1.
Dagenet
CB
,
De
DR
,
Shih
T
,
Brooks
B
,
Fixsen
D
,
Park
SE
, et al
.
Hurley staging training for hidradenitis suppurativa patients
.
Skin Appendage Disord
.
2024
;
10
(
6
):
524
7
.